Pfizer Inc. buy Scotiabank
Start price
14.11.25
/
50%
€21.90
Target price
14.11.26
-
Performance (%)
-0.73%
Price
21.11.25
€21.74
Summary
This prediction is currently active. Since the start of the prediction for Pfizer Inc. the price has only changed by -0.73%. This prediction currently runs until 14.11.26. The prediction end date can be changed by Scotiabank at any time. Scotiabank has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Pfizer Inc. | 0.741% |
| iShares Core DAX® | -2.673% |
| iShares Nasdaq 100 | -2.173% |
| iShares Nikkei 225® | -3.367% |
| iShares S&P 500 | -1.015% |
Comments by Scotiabank for this prediction
In the thread Pfizer Inc. diskutieren
Pfizer (NYSE:PFE) was upgraded by analysts at Scotiabank to a "strong-buy" rating.
Ratings data for PFE provided by MarketBeat